Extremities

Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)

ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

The AVITRAC™ MTP Revision System was created to provide an option when revising a failed Synthetic Cartilage Implant (SCI) to MTP arthrodesis. The system contains grafts in three different size options (Ø9 mm, Ø11 mm, Ø13 mm) to address the void left in the head of the metatarsal upon removal of an SCI implant. Sterile packaged reamers are included that are true to size in order to properly prepare the void for introduction of the AVITRAC™ graft.

AVITRAC™ is the only aseptically processed allograft solution available on the market to address SCI revisions. Gamma irradiation and bleaching are avoided during processing to maintain the structural integrity and osteoinductivity of the graft1,2,3. These strict tissue handling guidelines ensure the highest quality allograft is provided for these revisions.

For more information, please visit http://www.paragon28.com/

Sources Cited:

1. Mitchell EJ, Stawarz AM, Kayacan R, Rimnac CM. The effect of gamma radiation sterilization on the fatigue crack propagation resistance of human cortical bone. J Bone Joint Surg Am (2004); 86-A(12): 2648-57.

2. Carpenter EM, Gendler E, Malinin TI, Temple HT. Effect of hydrogen peroxide on osteoinduction by demineralized bone. AM J Orthop (2006); 35(12): 562-7.

3. DePaula CA, Truncale KG, Gertzman AA, Sunwoo MH, Dunn MG. Effects of hydrogen peroxide cleaning procedures on bone graft osteoinductivity and mechanical properties. Cell Tissue Bank (2005); 6(4): 287-98.

CONTACT:
Jim Edson
jedson@paragon28.com

SOURCE Paragon 28

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button
Close